VectorY

Amsterdam, The Netherlands

VectorY is an integrated gene therapy company focused on development of therapeutics for CNS, somatic disorders and muscle diseases.

$138.0M raised

Nov 2023

Series A

Top Investors

Insight PartnersEQT Life SciencesBioGeneration VenturesMRL Ventures FundBenhamou Global Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has VectorY raised?

VectorY has raised $138.0M in total funding. The most recent round was Series A. The last funding was announced in November 2023.

Who are VectorY's investors?

VectorY's investors include Insight Partners, EQT Life Sciences, BioGeneration Ventures, MRL Ventures Fund, Benhamou Global Ventures.

Where is VectorY headquartered?

VectorY is headquartered in Amsterdam, The Netherlands.

What does VectorY do?

VectorY is an integrated gene therapy company focused on development of therapeutics for CNS, somatic disorders and muscle diseases.

What stage is VectorY at?

VectorY is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 13, 2023.

MLA

"VectorY — Funding & Investors." VCBacked, November 13, 2023, https://www.vcbacked.co/company/vectory. Accessed June 17, 2026.

APA

VCBacked. (2023). VectorY — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/vectory

Wikipedia (cite web)

{{cite web |title=VectorY — Funding & Investors |url=https://www.vcbacked.co/company/vectory |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 13, 2023.